Mark H. Perrone

4.0k total citations
81 papers, 3.3k citations indexed

About

Mark H. Perrone is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark H. Perrone has authored 81 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark H. Perrone's work include Receptor Mechanisms and Signaling (11 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Cardiac Ischemia and Reperfusion (10 papers). Mark H. Perrone is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Cardiac Ischemia and Reperfusion (10 papers). Mark H. Perrone collaborates with scholars based in United States, Switzerland and China. Mark H. Perrone's co-authors include William T. Talman, Donald J. Reis, Dilip Amin, Patricia M. Hinkle, Linda Merkel, Glenda E. Bilder, Deborah A. Scheuer, Cyrille Maugeais, Daniel J. Rader and Kevin J. Lynch and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Mark H. Perrone

81 papers receiving 3.1k citations

Peers

Countries citing papers authored by Mark H. Perrone

Since Specialization

Citations

This map shows the geographic impact of Mark H. Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Perrone more than expected).

Fields of papers citing papers by Mark H. Perrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Perrone. The network helps show where Mark H. Perrone may publish in the future.

Co-authorship network of co-authors of Mark H. Perrone

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Perrone. A scholar is included among the top collaborators of Mark H. Perrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Perrone. Mark H. Perrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ergoline‐Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy 2014 ·ChemMedChem ·Yves P. Auberson, Thomas Troxler, Xuechun Zhang, Charles R. Yang, Markus Fendt, Dominik Feuerbach, Yu‐Chih Liu, Bharat Lagu, Andreas Lerchner, Mark H. Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tielin Wang, Mark G. Bock	6
2	From Ergolines to Indoles: Improved Inhibitors of the Human H3 Receptor for the Treatment of Narcolepsy 2014 ·ChemMedChem ·Yves P. Auberson, Thomas Troxler, Xuechun Zhang, Charles R. Yang, Dominik Feuerbach, Yu‐Chih Liu, Bharat Lagu, Mark H. Perrone, Lijun Lei, Xiaoxia Shen, (unknown), Chunxiu Wang, (unknown), Karin Briner, Mark G. Bock	2
3	Stent-induced Restenosis in the Swine Coronary Artery Is Inhibited by a Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, TKI963 2003 ·Journal of Cardiovascular Pharmacology ·Glenda E. Bilder, Dilip Amin, Lisa Morgan, Matthew J. McVey, Saul Needle, Helen Galczenski, Robert J. Leadley, Wei He, Michael R. Myers, Alfred P. Spada, (unknown), (unknown), Mark H. Perrone	8
4	Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs 2001 ·Thrombosis Research ·Sam Rebello, Charles Kasiewski, Ross Bentley, (unknown), Valeria Chu, Jeffrey S. Bostwick, Scott I. Klein, Mark H. Perrone, Robert J. Leadley	13
5	Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs 2001 ·Journal of Cardiovascular Pharmacology ·Sam Rebello, Charles Kasiewski, Wei Wang, Ross Bentley, (unknown), Valeria Chu, Dennis Colussi, Karen Brown, Mark H. Perrone, Robert J. Leadley	9
6	Induction of heat shock protein 70 by herbimycin A and cyclopentenone prostaglandins in smooth muscle cells 2000 ·Cell Stress and Chaperones ·L T Hamel, (unknown), Zaid Jayyosi, Ali Ardati, (unknown), (unknown), Asher Zilberstein, Mark H. Perrone, June Kaplow, Linda Merkel, Camilo Rojas	13
7	Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis 2000 ·European Journal of Pharmacology ·Christopher L. Heran, (unknown), Charles Kasiewski, Jeffrey S. Bostwick, Ross Bentley, Scott I. Klein, Valeria Chu, Karen Brown, Dennis Colussi, (unknown), Mark H. Perrone, Robert J. Leadley	23
8	Cardiovascular Pharmacology of the Adenosine A1/A2-Receptor Agonist AMP 579: Coronary Hemodynamic and Cardioprotective Effects in the Canine Myocardium 1999 ·Journal of Cardiovascular Pharmacology ·Matthew J. McVey, Glenn J. Smits, Bryan F. Cox, Jan M. Kitzen, Kenneth L. Clark, Mark H. Perrone	32
9	Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa 1999 ·Journal of Cardiovascular Pharmacology ·Robert J. Leadley, (unknown), Ross Bentley, Jeffrey S. Bostwick, Charles Kasiewski, Christopher L. Heran, Valeria Chu, Karen Brown, (unknown), William R. Ewing, Henry W. Pauls, Alfred P. Spada, Mark H. Perrone, Christopher T. Dunwiddie	15
10	Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A₂‐ but not to an A₁‐agonist in the dog 1994 ·British Journal of Pharmacology ·Bryan F. Cox, (unknown), Mark H. Perrone, Linda Merkel	10
11	In vitro and in vivo characterization of an A1-selective adenosine agonist, RG14202. 1993 ·Journal of Pharmacology and Experimental Therapeutics ·Linda Merkel, (unknown), Dennis Colussi, Mark H. Perrone, Gerard Smits, B. F. Cox	23
12	Inhibition of EGF-Induced Vasoconstriction in Isolated Rabbit Aortic Rings with the Tyrosine Kinase Inhibitor RG50864 1993 ·Biochemical and Biophysical Research Communications ·Linda Merkel, (unknown), Dennis Colussi, Mark H. Perrone	13
13	The role of the neutrophil and formed elements of the blood in an in vitro model of reperfusion injury 1992 ·Mediators of Inflammation ·John Barrett, Claudia K. Derian, (unknown), Richard Woltmann, Mark H. Perrone	2
14	Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Linda Merkel, Rodney W. Lappe, (unknown), B. F. Cox, Mark H. Perrone	84
15	In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor 1992 ·European Journal of Pharmacology ·Linda Merkel, Luz María Ruíz‐Godoy Rivera, Mark H. Perrone, Rodney W. Lappe	29
16	Preclinical pharmacology of celiprolol: A cardioselective β-adrenergic antagonist and mild vasodilator 1991 ·American Heart Journal ·Mark H. Perrone, John Barrett	13
17	Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Mark H. Perrone, L T Hamel, (unknown), Dean R. Haubrich	7
18	Pharmacology of RG W-2938: A Cardiotonic Agent with Vasodilator Activity 1990 ·Journal of Cardiovascular Pharmacology ·John Barrett, Richard Woltmann, (unknown), Charles Kasiewski, William C. Faith, (unknown), Mark H. Perrone	22
19	Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Glenda E. Bilder, Charles Kasiewski, Mark H. Perrone	16
20	Lovastatin is hypertriglyceridemic in Syrian Golden hamsters 1988 ·Biochemical and Biophysical Research Communications ·Dilip Amin, (unknown), Mark H. Perrone	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact